Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsor: Eli Lilly and Company
Summary
The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.
Official title: A Master Protocol for a Randomized, Controlled, Clinical Platform Trial to Investigate the Efficacy and Safety of Interventions for Chronic Weight Management in Pediatric Participants With Obesity or Overweight
Key Details
Gender
All
Age Range
6 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
125
Start Date
2024-11-18
Completion Date
2027-03
Last Updated
2026-03-24
Healthy Volunteers
No
Conditions
Interventions
Orforglipron
Administered orally. ISA specific interventions will be listed in the ISA.
Placebo
Administered orally. ISA specific interventions will be listed in the ISA.
Locations (41)
Carey Chronis MD Pediatric, Infant and Adolescent Medicine
Ventura, California, United States
Yale School of Medicine - Yale Diabetes Center (YDC)) Trials
New Haven, Connecticut, United States
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Children's Healthcare of Atlanta - Center for Advanced Pediatrics
Atlanta, Georgia, United States
Ann and Robert Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Velocity Clinical Research
Lafayette, Louisiana, United States
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Gulfport, Mississippi, United States
Sundance Clinical Research
St Louis, Missouri, United States
Velocity Clinical Research
Omaha, Nebraska, United States
Lucas Research, Inc
Morehead City, North Carolina, United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Vanderbilt Health One Hundred Oaks
Nashville, Tennessee, United States
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Houston, Texas, United States
La Providence Pediatrics Clinic - Chemidox Clinical Trials
Houston, Texas, United States
Martin Diagnostic Clinic
Tomball, Texas, United States
Velocity Clinical Research, Salt Lake City
West Jordan, Utah, United States
L2IP - Instituto de Pesquisas Clínicas
Brasília, Brazil
Hospital Universitario de Caxias do Sul
Caxias do Sul, Brazil
CPQuali Pesquisa Clínica Sao Paulo
São Paulo, Brazil
Yitzhak Shamir Medical Center
Beer Yaacov, Israel
Shaare Zedek Medical Center
Jerusalem, Israel
Chaim Sheba Medical Center
Ramat Gan, Israel
Azienda Ospedaliero Universitaria Meyer
Florence, Italy
Azienda Ospedaliero Universitaria Maggiore della Carità
Novara, Italy
Ospedale Pediatrico Bambino Gesù
Roma, Italy
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento
Verona, Italy
Centro Para el Desarrollo de la Medicina y de Asistencia Especializada SC
Culiacán, Mexico
PanAmerican Clinical Research - Guadalajara
Guadalajara, Mexico
Innovacion y Desarrollo de Estrategias en Salud SA de CV
Mexico City, Mexico
Hospital Angeles Puebla
Puebla City, Mexico
Krakowskie Centrum Medyczne
Krakow, Poland
Instytut Diabetologii
Warsaw, Poland
FutureMeds - Targowek
Warsaw, Poland
FutureMeds sp. z o. o.
Wroclaw, Poland
Barnsley Hospital NHS Foundation Trust
Barnsley, United Kingdom
Bristol Royal Hospital for Children
Bristol, United Kingdom
Addenbrookes Hospital
Cambridge, United Kingdom
Ninewells Hospital
Dundee, United Kingdom
Northwick Park Hospital
Harrow, United Kingdom
Hull Royal Infirmary - MAIN
Hull, United Kingdom
Alder Hey Children's Hospital
Liverpool, United Kingdom